Shaun Bagai
CEO at RenovoRx Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: RenovoRx Inc., 3 years.
RenovoRx Inc.
Director · Chief Executive Officer
Chief executive roles
RenovoRx Inc.
· CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | RenovoRx Inc. | Open-market purchase | +24,300 | — | — |
| Dec 18, 2025 | RenovoRx Inc. | Open-market purchase | +5,000 | $0.90 | $4,500 |
| Dec 17, 2025 | RenovoRx Inc. | Open-market purchase | +5,000 | $0.85 | $4,250 |
| Aug 25, 2025 | RenovoRx Inc. | Open-market purchase | +5,000 | $0.91 | $4,550 |
| Aug 22, 2025 | RenovoRx Inc. | Open-market purchase | +5,000 | $0.95 | $4,750 |
| Apr 15, 2025 | RenovoRx Inc. | Open-market purchase | +7,500 | $0.91 | $6,825 |
| Apr 9, 2025 | RenovoRx Inc. | Open-market purchase | +10,000 | $0.83 | $8,300 |
| Apr 7, 2025 | RenovoRx Inc. | Open-market purchase | +10,000 | $0.83 | $8,300 |
| Jan 26, 2024 | RenovoRx Inc. | Open-market purchase | +40,983 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.